Mary Ann Gray - Net Worth and Insider Trading
Mary Ann Gray Net Worth
The estimated net worth of Mary Ann Gray is at least $399,000 dollars as of 2024-11-13. Mary Ann Gray is the Director of Dyax Corp and owns about 10,000 shares of Dyax Corp (DYAX) stock worth over $384,100. Mary Ann Gray is the Director of Senomyx Inc and owns about 10,000 shares of Senomyx Inc (SNMX) stock worth over $14,900. Mary Ann Gray is also the Director of MabVax Therapeutics Holdings Inc and owns about 1 shares of MabVax Therapeutics Holdings Inc (MBVXQ) stock worth over $0. Besides these, Mary Ann Gray also holds ACADIA Pharmaceuticals Inc (ACAD) . Details can be seen in Mary Ann Gray's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mary Ann Gray has not made any transactions after 2017-03-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mary Ann Gray
Mary Ann Gray Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mary Ann Gray owns 14 companies in total, including RAPT Therapeutics Inc (RAPT) , Seneca Biopharma Inc (SNCA) , and Sarepta Therapeutics Inc (SRPT) among others .
Click here to see the complete history of Mary Ann Gray’s form 4 insider trades.
Insider Ownership Summary of Mary Ann Gray
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RAPT | RAPT Therapeutics Inc | 2019-12-04 | director |
| SNCA | Seneca Biopharma Inc | 2020-04-03 | director |
| SRPT | Sarepta Therapeutics Inc | 2018-12-10 | director |
 | | 2018-11-02 | director |
| | 2018-08-14 | director |
| | 2016-04-25 | director |
| | 2014-12-15 | director |
| | 2016-01-22 | other: Former director |
| | 2015-01-28 | director |
| | 2008-05-22 | director |
| | 2019-07-19 | director |
| | 2020-12-17 | director |
| | 2022-04-26 | director |
| | 2020-12-15 | director |
Mary Ann Gray Latest Holdings Summary
Mary Ann Gray currently owns a total of 4 stocks. Among these stocks, Mary Ann Gray owns 10,000 shares of Dyax Corp (DYAX) as of May 17, 2006, with a value of $384,100 and a weighting of 96.27%. Mary Ann Gray owns 10,000 shares of Senomyx Inc (SNMX) as of March 24, 2017, with a value of $14,900 and a weighting of 3.73%. Mary Ann Gray also owns 1 shares of MabVax Therapeutics Holdings Inc (MBVXQ) as of March 16, 2005, with a value of $0 and a weighting of 0%. The other 1 stocks ACADIA Pharmaceuticals Inc (ACAD) have a combined weighting of 0% among all his current holdings.
Latest Holdings of Mary Ann Gray
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DYAX | Dyax Corp | 2006-05-17 | 10,000 | 38.41 | 384,100 |
| SNMX | Senomyx Inc | 2017-03-24 | 10,000 | 1.49 | 14,900 |
| MBVXQ | MabVax Therapeutics Holdings Inc | 2005-03-16 | 1 | 0.02 | 0 |
| ACAD | ACADIA Pharmaceuticals Inc | 2014-12-15 | 0 | 17.94 | 0 |
Holding Weightings of Mary Ann Gray
Mary Ann Gray Form 4 Trading Tracker
According to the SEC Form 4 filings, Mary Ann Gray has made a total of 0 transactions in Dyax Corp (DYAX) over the past 5 years. The most-recent trade in Dyax Corp is the acquisition of 10,000 shares on May 17, 2006, which cost Mary Ann Gray around $29,400.
According to the SEC Form 4 filings, Mary Ann Gray has made a total of 0 transactions in Senomyx Inc (SNMX) over the past 5 years. The most-recent trade in Senomyx Inc is the acquisition of 10,000 shares on March 24, 2017, which cost Mary Ann Gray around $10,000.
According to the SEC Form 4 filings, Mary Ann Gray has made a total of 0 transactions in MabVax Therapeutics Holdings Inc (MBVXQ) over the past 5 years. The most-recent trade in MabVax Therapeutics Holdings Inc is the acquisition of 1 shares on March 16, 2005, which cost Mary Ann Gray around $77,800.
More details on Mary Ann Gray's insider transactions can be found in the Insider Trading History of Mary Ann Gray table.Insider Trading History of Mary Ann Gray
- 1
Mary Ann Gray Trading Performance
GuruFocus tracks the stock performance after each of Mary Ann Gray's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mary Ann Gray is -8.09%. GuruFocus also compares Mary Ann Gray's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mary Ann Gray within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mary Ann Gray's insider trading performs compared to the benchmark.
Performance of Mary Ann Gray
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -2.22 | | | | | |
| Relative Return to S&P 500(%) | -0.88 | | | | | |
Mary Ann Gray Ownership Network
Ownership Network List of Mary Ann Gray
Ownership Network Relation of Mary Ann Gray
Mary Ann Gray Owned Company Details
What does RAPT Therapeutics Inc do?
Who are the key executives at RAPT Therapeutics Inc?
Mary Ann Gray is the director of RAPT Therapeutics Inc. Other key executives at RAPT Therapeutics Inc include Chief Scientific Officer Dirk G. Brockstedt , Chief Medical Officer William Ho , and 10 percent owner Column Group Ii, Lp .
RAPT Therapeutics Inc (RAPT) Insider Trades Summary
Over the past 18 months, Mary Ann Gray made no insider transaction in RAPT Therapeutics Inc (RAPT). Other recent insider transactions involving RAPT Therapeutics Inc (RAPT) include a net sale of 9,000 shares made by William Ho , and a net sale of 898 shares made by Dirk G. Brockstedt .
In summary, during the past 3 months, insiders sold 0 shares of RAPT Therapeutics Inc (RAPT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 9,898 shares of RAPT Therapeutics Inc (RAPT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 9,898 shares.
RAPT Therapeutics Inc (RAPT)'s detailed insider trading history can be found in Insider Trading Tracker table.
RAPT Therapeutics Inc Insider Transactions
Mary Ann Gray Mailing Address
Above is the net worth, insider trading, and ownership report for Mary Ann Gray. You might contact Mary Ann Gray via mailing address: 201 W 70th St, Suite 23k, New York Ny 10023.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
